The need for more robust informatics tools to support antibody engineering has never been more important. Ongoing design, characterization, and process development decisions will have significant implications on their ability to bring new antibody therapeutics to market. In this presentation we highlight how Benchling, a leading cloud-based enterprise laboratory informatics platform, helps cross-functional teams speed and scale antibody production — all while ensuring the full traceability of sequences, samples, processes, and production outputs.
